Phase 3 Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stage 4 colorectal cancer (bowel cancer that has spread to other parts of the body).
Who may not be able to join:
- People who have agranulocytosis (a condition where the body has very low levels of a type of white blood cell that fights infection).
- People who are pregnant.
- People who have a known allergy to mebendazole (a medication commonly used to treat parasitic worm infections).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Reham El-ghoneimy, Msc, Tanta University - Faculty of Pharmacy
Phone: 00201147773440
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
number of patients with tumour response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.